Aberrant Expression Of Gremlin1 Induces Trophoblast Senescence In The Placenta Of Advanced Maternal Age Pregnancy
As women choose to have children later in life, pregnancies at an advanced maternal age (AMA) are becoming more common. However, these pregnancies often come with a higher risk of complications for both mother and baby. A key factor contributing to these issues is the premature aging of the placenta, the vital organ that supports fetal development. This early aging, known as senescence, can impair the placenta’s ability to function properly.
Recent research has shed light on a specific protein, Gremlin1 (GREM1), and its role in this process. Studies have found significantly higher levels of Gremlin1 in the placentas of women of advanced maternal age. When Gremlin1 is overactive, it can cause important placental cells, called trophoblasts, to age prematurely. These trophoblast cells are crucial for the placenta’s growth and function, including its ability to invade the uterine wall and establish a healthy connection.
The mechanism behind this involves Gremlin1 interfering with a critical cellular communication pathway known as BMP4-SMAD signaling. This pathway is essential for maintaining the health and function of trophoblast cells. By disrupting this signaling, Gremlin1 promotes the premature aging of these cells, hindering their ability to multiply, move, and invade as needed for a healthy pregnancy.
Understanding this process could open doors for new strategies to support healthier pregnancies in women of advanced maternal age by targeting Gremlin1 or the pathways it affects.
Source: link to paper